Abstract

From their analysis the pooled mortality rate for patients with CKD stage 3 was 1.5 times higher (Hazard ratio 1.46, 95%CI 1.41–1.51) and 2.8 times higher for higher stages of CKD (harzard ratio 2.84, 95% 2.69–2.99) [7]. Current trends in proteinuria screening in CKD have improved but continue to vary widely, noted to be between 10 and 45% in one large health care system in the US [10]. The National Kidney Foundation and The American Society of Nephrology recently lead a task force to look at the formula to estimate GFR and have identified race as a social construct and not appropriate to be part of the estimated GFR equation. [...]primary care practitioners make up the largest portion of the US providers work force and according to the Agency for Healthcare Research and Quality, are primed to meet the goals of the triple aim of US healthcare by improving quality of care, containing costs, and improving patient experience (18). [...]identifying those at risk or with CKD and preventing complications of CKD will be essential skills for the primary care practitioner with an aging patient population.

Details

Title
Prime time for chronic kidney disease
Author
Weisman, David S; Thavarajah, Sumeska; Jaar, Bernard G
Pages
1-4
Section
Editorial
Publication year
2023
Publication date
2023
Publisher
BioMed Central
e-ISSN
14712369
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2877491413
Copyright
© 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.